drugset / Trial / NCT06873282
Phase 2 Study of the ТВ/Flu-05Е Tuberculosis Vaccine
Phase 2
Completed
160 enrolled
Research Institute of Influenza, Russia
Pavlov First Saint Petersburg State Medical University · collabSt. Petersburg City Polyclinic No. 34 · collab
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of the study is to investigate immunogenicity and safety of the TB/Flu-05E single-dose intranasal vaccine for the prevention of Tuberculosis infection in BCG-vaccinated Volunteers aged 18-50 years
Timeline
- Start
- 2023-12-13
- Primary completion
- 2024-01-12
- Completion
- 2024-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TB/Flu-05E | Vaccine | 0.5 ml | Intranasal |
| Subject | TB/Flu-05E | Vaccine | 7.7 unknown | Intranasal |